Healion Bio Overview
- Year Founded
-
2020
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$1.2M
Healion Bio General Information
Description
Developer of medicines intended to cure and prevent infectious diseases for which there are few or no good treatment options. The company specializes in layered defense against diseases which includes diagnostics, vaccines, prophylactics, and therapeutics by combining excellence in science with entrepreneurial creativity, enabling pharma companies, universities, and government labs to get to a safe, workable, and improved health quickly.
Contact Information
Website
www.healionbio.comCorporate Office
- Frederick Innovation Technology Center
- 4539 Metropolitan Court
- Frederick, MD 21704
- United States
Corporate Office
- Frederick Innovation Technology Center
- 4539 Metropolitan Court
- Frederick, MD 21704
- United States
Healion Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Merger/Acquisition | 02-Feb-2023 | $1.2M | Completed | Generating Revenue | ||
| 1. Early Stage VC | 17-Feb-2021 | Completed | Generating Revenue |
Healion Bio Comparisons
Industry
Financing
Details
Healion Bio Competitors (2)
One of Healion Bio’s 2 competitors is RNAimmune, a Venture Capital-Backed company based in MD.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| RNAimmune | Venture Capital-Backed | MD | ||||
| Immunomic Therapeutics | Venture Capital-Backed | Rockville, MD |
Healion Bio Patents
Healion Bio Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2022072504-A1 | Methods and compositions for the treatment of viral diseases | Inactive | 29-Sep-2020 | ||
| WO-2021231872-A1 | Compositions and methods for increasing efficacy of a drug | Inactive | 15-May-2020 | ||
| US-20230142126-A1 | Methods and compositions for the treatment of viral diseases | Inactive | 15-May-2020 | A61K31/495 |
Healion Bio Former Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Visionary Private Equity Group | PE/Buyout |
Healion Bio FAQs
-
When was Healion Bio founded?
Healion Bio was founded in 2020.
-
Where is Healion Bio headquartered?
Healion Bio is headquartered in Frederick, MD.
-
What industry is Healion Bio in?
Healion Bio’s primary industry is Drug Discovery.
-
Is Healion Bio a private or public company?
Healion Bio is a Private company.
-
What is the current valuation of Healion Bio?
The current valuation of Healion Bio is .
-
What is Healion Bio’s current revenue?
The current revenue for Healion Bio is .
-
Who are Healion Bio’s investors?
Visionary Private Equity Group has invested in Healion Bio.
-
Who are Healion Bio’s competitors?
RNAimmune and Immunomic Therapeutics are competitors of Healion Bio.
-
When was Healion Bio acquired?
Healion Bio was acquired on 02-Feb-2023.
-
Who acquired Healion Bio?
Healion Bio was acquired by Tonix Pharmaceuticals Holding.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process